News coverage about Vascular Solutions (NASDAQ:VASC) has been trending positive on Monday, Alpha One Sentiment Analysis reports. Alpha One, a service of Accern, identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Alpha One ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Vascular Solutions earned a news sentiment score of 0.31 on Alpha One’s scale. Alpha One also assigned headlines about the medical device company an impact score of 0 out of 100, meaning that recent news coverage is extremely unlikely to have an effect on the company’s share price in the next several days.

Here are some of the news headlines that may have effected AlphaOne Sentiment Analysis’s rankings:

Separately, Zacks Investment Research downgraded shares of Vascular Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, December 28th. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $51.80.

Vascular Solutions (NASDAQ:VASC) opened at 56.00 on Monday. The company’s 50-day moving average is $55.89 and its 200 day moving average is $51.22. Vascular Solutions has a 12 month low of $25.06 and a 12 month high of $57.15.

WARNING: This piece was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/04/24/vascular-solutions-vasc-receives-daily-news-impact-rating-of-0-31.html.

About Vascular Solutions

Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.

5 Day Chart for NASDAQ:VASC

Receive News & Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.